Ocugen reports positive Phase II/III data for Covid-19 vaccine in children
In the paediatric Phase II/III trial, the vaccine showed no serious adverse events or mortality.
Covid-19
Latest in
Covid-19
Bharat’s Phase II/III Covaxin trial shows safety in children
Vaccine-linked cases of AEFIs such as myocarditis, blood clots and pericarditis were not found with Covaxin.
Moleculin reports data from first cohort of Phase Ia Covid-19 prodrug trial
The Phase Ia trial is evaluating effects of WP1122 when administered as an oral solution in healthy participants.
Prothione capsules reduce Covid-19 viral load in Phase II trial
The antiviral offered a decline in time to clinical resolution as described by the time to achieve three negative RT-PCR…
PureTech reports Phase II data of LYT-100 for long Covid
According to the findings, no treatment effect was reported following LYT-100 administration.
Sanofi-GSK’s Covid-19 booster offers immune response against variants
In the two trials, the next-generation vaccine candidate was well-tolerated with a favourable safety profile.
Immunome doses first subject in Phase Ib trial of Covid-19 treatment
Analysing safety is the primary endpoint of the trial while PK and virology will be the secondary assessments.
Tighter European trial regulations likely due to Covid-19 research waste
With a number of Covid-19 clinical trials in Europe now considered as research waste, sponsors should prepare for more guidelines.
By